Reconstruction of exposure to m-xylene from human biomonitoring data using PBPK modelling, bayesian inference, and Markov chain Monte Carlo simulation

Journal of Toxicology

Volumn 2012, Issue , 2012, Pages

  McNally, Kevin ^a   Cotton, Richard ^a   Cocker, John ^a   Jones, Kate ^a   Bartels, Mike ^b   Rick, David ^b   Price, Paul ^b   Loizou, George ^a  

^a HEALTH AND SAFETY LABORATORY   (United Kingdom)

^b DOW CHEMICAL COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLHIPPURIC ACID; HIPPURIC ACID DERIVATIVE; UNCLASSIFIED DRUG; XYLENE;

ADULT; ARTICLE; BAYES THEOREM; BIOLOGICAL MONITORING; DOSIMETRY; ENVIRONMENTAL EXPOSURE; EXHALATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MATHEMATICAL MODEL; MONTE CARLO METHOD; NORMAL HUMAN; PRIORITY JOURNAL; PROBABILITY; SIMULATION; VENOUS BLOOD;

EID: 84861081521     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2012/760281     Document Type: Article

References (48)

1. Consortium to Perform Human Biomonitoring on a European Scale (COPHES),. Human Biomonitoring For Europe: A Harmonised Approach: http://www.eu-hbm.info/ cophes
2. ESBIO,. Expert Team to Support Biomonitoring in Europe: http://www.eu-humanbiomonitoring.org/sub/esbio.htm
3. Centers for Disease Control and Prevention (CDC),. National Biomonitoring Program: http://www.cdc.gov/biomonitoring/environmentalchemicals.html
4. Canadian Health Measures Survey (CHMS),. Canadian Health Measures Survey: http://www.statcan.gc.ca/cgi-bin/imdb/p2SV.pl?Function=getSurveySDDS=5071lang= endb=imdbadm=8dis=2
5. Boogaard P. J., Hays S. M., Aylward L. L., Human biomonitoring as a pragmatic tool to support health risk management of chemicalsexamples under the EU REACH programme Regulatory Toxicology and Pharmacology 2011 59 1 125 132
6. Manno M., Viau C., Cocker J., Colosio C., Lowry L., Mutti A., Nordberg M., Wang S., Biomonitoring for occupational health risk assessment (BOHRA) Toxicology Letters 2010 192 1 3 16
7. National Research Council, Human Biomonitoring for Environmental Chemicals 2006 Washington, DC, USA National Academies Press
8. Clewell H. J., Tan Y. M., Campbell J. L., Andersen M. E., Quantitative Interpretation of Human Biomonitoring Data Toxicology and Applied Pharmacology 2008 231 1 122 133
9. Liao K. H., Tan Y. M., Clewell H. J., Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene Risk Analysis 2007 27 5 1223 1236 (Pubitemid 350222035)
10. Lyons M. A., Yang R. S. H., Mayeno A. N., Reisfeld B., Computational toxicology of chloroform: reverse dosimetry using Bayesian inference, Markov chain Monte Carlo simulation, and human biomonitoring data Environmental Health Perspectives 2008 116 8 1040 1046
11. Tan Y. M., Liao K. H., Clewell H. J., Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling Journal of Exposure Science and Environmental Epidemiology 2007 17 7 591 603 (Pubitemid 350126884)
12. Tan Y. M., Liao K., Conolly R., Blount B., Mason A., Clewell H., Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform Journal of Toxicology and Environmental Health A 2006 69 18 1727 1756 (Pubitemid 44174510)
13. Georgopoulos P. G., Roy A., Gallo M. A., Reconstruction of short-term multi-route exposure to volatile organic compounds using physiologically based pharmacokinetic models Journal of Exposure Analysis and Environmental Epidemiology 1994 4 3 309 328 (Pubitemid 24335163)
14. Roy A., Georgopoulos P. G., Reconstructing week-long exposures to volatile organic compounds using physiologically based pharmacokinetic models Journal of Exposure Analysis and Environmental Epidemiology 1998 8 3 407 422 (Pubitemid 28375674)
15. Mosquin P. L., Licata A. C., Liu B., Sumner S. C. J., Okino M. S., Reconstructing exposures from small samples using physiologically based pharmacokinetic models and multiple biomarkers Journal of Exposure Science and Environmental Epidemiology 2009 19 3 284 297
16. Gelman A., Bois F., Jiang J., Physiological pharmacokinetic analysis using population modeling and informative prior distributions Journal of the American Statistical Association 1996 91 436 1400 1412
17. Bernillon P., Bois F. Y., Statistical issues in toxicokinetic modeling: a Bayesian perspective Environmental Health Perspectives 2000 108 5 883 893
18. Hack C. E., Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models Toxicology 2006 221 2-3 241 248
19. Jonsson F., Johanson G., Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene Toxicology 2001 157 3 177 193 (Pubitemid 32115454)
20. Covington T. R., Robinan Gentry P., van Landingham C. B., Andersen M. E., Kester J. E., Clewell H. J., The use of Markov chain Monte Carlo uncertainty analysis to support a public health goal for perchloroethylene Regulatory Toxicology and Pharmacology 2007 47 1 1 18 (Pubitemid 44765120)
21. Hadamard J., Sur les problemes aux derivees partielles et leur signification physique Bulletin of the University of Princeton 1902 13 49 52
22. Sohn M. D., McKone T. E., Blancato J. N., Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study Journal of Exposure Analysis and Environmental Epidemiology 2004 14 3 204 213 (Pubitemid 38765943)
23. Allen B. C., Hack C. E., Clewell H. J., Use of Markov chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in U.S. women of childbearing age Risk Analysis 2007 27 4 947 959 (Pubitemid 47631881)
24. McNally K., Cotton R., Loizou G., A workflow for global sensitivity analysis of PBPK models, Frontiers in Pharmacology Predictive Toxicity 2011 2 article 31 1 21
25. Dyne D., Cocker J., Wilson H. K., A novel device for capturing breath samples for solvent analysis Science of the Total Environment 1997 199 1-2 83 89 (Pubitemid 27261823)
26. Loizou G. D., Jones K., Akrill P., Dyne D., Cocker J., Estimation of the dermal absorption of m-xylene vapor in humans using breath sampling and physiologically based pharmacokinetic analysis Toxicological Sciences 1999 48 2 170 179 (Pubitemid 29226694)
27. Bonsnes R. W., Taussky H. H., On the colorimetric determination of creatinine by the Jaffe reaction Journal of Biological Chemistry 1945 158 581 591
28. Tardif R., Sato A., Lapare S., Brodeur J., Ethanol induced modification of m-xylene toxicokinetics in humans Occupational and Environmental Medicine 1994 51 3 187 191 (Pubitemid 24106166)
29. Campbell L., Wilson H. K., Samuel A. M., Gompertz D., Interactions of m-xylene and aspirin metabolism in man British Journal of Industrial Medicine 1988 45 2 127 132 (Pubitemid 18065643)
30. Franks S. J., Spendiff M. K., Cocker J., Loizou G. D., Physiologically based pharmacokinetic modelling of human exposure to 2-butoxyethanol Toxicology Letters 2006 162 2-3 164 173 (Pubitemid 43243137)
31. MacDonald A. J., Rostami-Hodjegan A., Tucker G. T., Linkens D. A., Analysis of solvent central nervous system toxicity and ethanol interactions using a human population physiologically based kinetic and dynamic model Regulatory Toxicology and Pharmacology 2002 35 2 165 176 (Pubitemid 34664918)
32. Tassaneeyakul W., Birkett D. J., Edwards J. W., Veronese M. E., Tassaneeyakul W., Tukey R. H., Miners J. O., Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene 1 Journal of Pharmacology and Experimental Therapeutics 1996 276 1 101 108
33. Howgate E. M., Rowland Yeo K., Proctor N. J., Tucker G. T., Rostami-Hodjegan A., Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability Xenobiotica 2006 36 6 473 497 (Pubitemid 43890728)
34. Barter Z. E., Bayliss M. K., Beaune P. H., Boobis A. R., Carlile D. J., Edwards R. J., Houston J. B., Lake B. G., Lipscomb J. C., Pelkonen O. R., Tucker G. T., Rostami-Hodjegan A., Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver Current Drug Metabolism 2007 8 1 33 45 (Pubitemid 46043890)
35. Willmann S., Hhn K., Edginton A., Sevestre M., Solodenko J., Weiss W., Lippert J., Schmitt W., Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs Journal of Pharmacokinetics and Pharmacodynamics 2007 34 3 401 431 (Pubitemid 46873033)
36. Engstrm K., Husman K., Pfffli P., Riihimaki V., Evaluation of occupational exposure to xylene by blood, exhaled air and urine analysis Scandinavian Journal of Work, Environment and Health 1978 4 2 114 121 (Pubitemid 8378716)
37. Brooks S. P., Markov chain Monte Carlo method and its application Journal of the Royal Statistical Society Series D 1998 47 1 69 100 (Pubitemid 128469062)
38. R Development Core Team, R: A Language and Environment for Statistical Computing 2010 Vienna, Austria R Foundation for Statistical Computing
39. Wickham H., Ggplot2: Elegant Graphics for Data Analysis 2009 New York, NY, USA Springer
40. Takahashi K.,. buildlegend, http://tiny.cc/lkl06, 2010
41. Andersen M. E., Sarangapani R., Reitz R. H., Gallavan R. H., Dobrev I. D., Plotzke K. P., Physiological modeling reveals novel pharmacokinetic behavior for inhaled octamethylcyclotetrasiloxane in rats Toxicological Sciences 2001 60 2 214 231 (Pubitemid 32273310)
42. Saltelli A., Tarantola S., Campolongo F., Ratto M., Sensitivity Analysis in Practice: A Guide to Assessing Scientific Models 2004 Chichester, UK John Wiley Sons
43. Campolongo F., Saltelli A., Sensitivity analysis of an environmental model: an application of different analysis methods Reliability Engineering and System Safety 1997 57 1 49 69 (Pubitemid 127399763)
44. Loizou G., Spendiff M., Barton H. A., Bessems J., Bois F. Y., d'Yvoire M. B., Buist H., Clewell H. J., Meek B., Gundert-Remy U., Goerlitz G., Schmitt W., Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps Regulatory Toxicology and Pharmacology 2008 50 3 400 411
45. World Health Organization (WHO), Characterization and application of physiologically based pharmacokinetic models in risk assessment Harmonization Project Document 2010 9 Geneva, Switzerland World Health Organization
46. O'Hagan A., Oakley J. E., Probability is perfect, but we can't elicit it perfectly Reliability Engineering and System Safety 2004 85 13 239 248
47. Oberkampf W. L., Helton J. C., Joslyn C. A., Wojtkiewicz S. F., Ferson S., Challenge problems: uncertainty in system response given uncertain parameters Reliability Engineering and System Safety 2004 85 13 11 19
48. Bois F. Y., Jamei M., Clewell H. J., PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals Toxicology 2010 278 3 256 267